Trial Profile
A Randomized, Open-labeled, Single-dose, Crossover Design Clinical Trial to Evaluate Pharmacokinetics and Safety of CJ-30056 20/750mg and Co-administration of Lipitor® 20mg and Glucophage SR 750mg in Fed Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Atorvastatin/metformin (Primary) ; Atorvastatin; Metformin
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors CJ HealthCare; HK inno.N
- 29 Dec 2016 Status changed from not yet recruiting to completed.
- 09 Mar 2015 New trial record